Greenway Greenhouse Cannabis Corp. (TSE:GWAY)
:GWAY
Top Page
Greenway Greenhouse Cannabis Corp.
(GWAY)
Select Model
Select Model
Rating:41Neutral
Price Target:
C$0.18
▲(6.47% Upside)
Action:ReiteratedDate:03/10/26
The score is weighed down primarily by weak financial quality (ongoing net losses, high leverage, and negative/volatile cash flow) despite some improvement in operating profitability. Technicals also remain bearish (negative MACD, RSI below 50, and price below the 200-day average). Valuation provides limited support because the company is loss-making (negative P/E) and there is no dividend yield.
Positive Factors
Greenhouse cultivation business model
Greenway's greenhouse-based cultivation tied to Canada’s regulated supply chain supports scalable, repeatable production and predictable wholesale channels. This business model aligns with provincial distribution systems and B2B supply, giving a durable platform for volume-led revenue in the medium term.
Negative Factors
High leverage
Elevated debt relative to equity increases financial risk and constrains strategic flexibility. With leverage higher than prior years, the firm faces greater interest and refinancing exposure; a downturn in operating performance would more quickly pressure liquidity and capital allocation choices.
Read all positive and negative factors
Positive Factors
Negative Factors
Greenhouse cultivation business model
Greenway's greenhouse-based cultivation tied to Canada’s regulated supply chain supports scalable, repeatable production and predictable wholesale channels. This business model aligns with provincial distribution systems and B2B supply, giving a durable platform for volume-led revenue in the medium term.
Read all positive factors
Greenway Greenhouse Cannabis Corp. (GWAY) vs. iShares MSCI Canada ETF (EWC)
Market Cap
C$21.26M
Dividend YieldN/A
Average Volume (3M)19.31K
Price to Earnings (P/E)―
Beta (1Y)0.82
Revenue Growth19.66%
EPS Growth84.34%
CountryCA
Employees10
SectorHealthcare
Sector Strength45
IndustryDrug Manufacturers - Specialty & Generic
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding132,844,530
10 Day Avg. Volume16,837
30 Day Avg. Volume19,312
Financial Highlights & Ratios
PEG Ratio0.22
Price to Book (P/B)2.75
Price to Sales (P/S)3.09
P/FCF Ratio17.14
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Greenway Greenhouse Cannabis Corp. Business Overview & Revenue Model
Company Description
Greenway Greenhouse Cannabis Corporation engages in the cultivation, processing, and selling of dried cannabis flower and kief. The company was incorporated in 2018 and is based in Kingsville, Canada. Greenway Greenhouse Cannabis Corporation is a ...
How the Company Makes Money
Greenway Greenhouse Cannabis Corp. generates revenue primarily through the commercial production (cultivation) and sale of cannabis and cannabis-derived products. Its core revenue stream is wholesale/B2B sales to other licensed cannabis companies ...
Greenway Greenhouse Cannabis Corp. Financial Statement Overview
Summary
Income Statement
54
Neutral
Balance Sheet
42
Neutral
Cash Flow
38
Negative
| Breakdown | TTM | Jun 2024 | Jun 2023 | Jun 2022 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 9.13M | 8.95M | 5.23M | 5.62M | 1.98M | 0.00 |
| Gross Profit | 3.53M | 1.68M | -335.38K | 741.99K | 844.02K | 487.88K |
| EBITDA | 2.76M | 972.53K | -2.21M | -632.92K | -1.36M | -727.12K |
| Net Income | -213.13K | -2.06M | -4.72M | -2.61M | -2.92M | -1.23M |
Balance Sheet | ||||||
| Total Assets | 32.63M | 32.26M | 33.09M | 35.30M | 35.63M | 25.11M |
| Cash, Cash Equivalents and Short-Term Investments | 1.18M | 3.14M | 1.53M | 3.64M | 7.48M | 3.46M |
| Total Debt | 15.63M | 15.79M | 16.02M | 13.96M | 16.67M | 13.85M |
| Total Liabilities | 22.81M | 22.21M | 21.17M | 20.36M | 18.77M | 14.85M |
| Stockholders Equity | 9.82M | 10.05M | 11.92M | 14.95M | 16.86M | 10.26M |
Cash Flow | ||||||
| Free Cash Flow | -975.90K | 1.61M | -4.96M | -4.38M | -4.10M | -5.95M |
| Operating Cash Flow | -779.77K | 1.81M | -2.05M | 2.23M | -1.97M | -592.08K |
| Investing Cash Flow | -196.13K | -194.37K | -2.92M | 428.31K | -2.12M | -5.36M |
| Financing Cash Flow | 0.00 | 0.00 | 2.85M | -6.49M | 8.12M | 7.97M |
Greenway Greenhouse Cannabis Corp. Technical Analysis
Negative
0.17
Price Trends
0.16
Negative
0.17
Negative
0.19
Negative
Market Momentum
<0.01
Positive
42.79
Neutral
22.22
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For TSE:GWAY, the sentiment is Negative. The current price of 0.17 is below the 20-day moving average (MA) of 0.17, above the 50-day MA of 0.16, and below the 200-day MA of 0.19, indicating a bearish trend. The MACD of <0.01 indicates Positive momentum. The RSI at 42.79 is Neutral, neither overbought nor oversold. The STOCH value of 22.22 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for TSE:GWAY.
Greenway Greenhouse Cannabis Corp. Peers Comparison
UnderperformOutperform
Sector (51)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
65 Neutral | C$34.26M | 29.79 | 7.78% | ― | 28.55% | ― | |
51 Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% | |
49 Neutral | C$27.35M | -3.31 | -19.10% | ― | 18.06% | 34.58% | |
47 Neutral | C$18.85M | -7.21 | -68.32% | ― | 2.41% | 74.61% | |
45 Neutral | C$6.92M | -1.86 | ― | ― | 15.64% | 58.47% | |
41 Neutral | C$21.26M | -44.16 | -2.15% | ― | 19.66% | 84.34% | |
40 Neutral | C$18.10M | -0.04 | ― | ― | 0.63% | -31.86% |
* Healthcare Sector Average
TSE:GWAY
Greenway Greenhouse Cannabis Corp.
0.16
-0.03
-15.79%
TSE:AYR.A
Ayr Wellness
0.16
-0.05
-22.50%
TSE:LABS
MediPharm Labs
0.07
-0.02
-18.75%
TSE:PCLO
PharmaCielo
0.05
-0.04
-47.06%
TSE:ROMJ
Rubicon Organics
0.51
0.02
4.08%
TSE:AVCN
Avicanna
0.15
-0.07
-31.82%
Greenway Greenhouse Cannabis Corp. Corporate Events
Business Operations and StrategyFinancial Disclosures
Greenway Lifts Revenue, Margins and Cash Efficiency in Q3 Results
Positive
Feb 25, 2026
Greenway Greenhouse Cannabis Corp. reported a 40% year-over-year increase in third-quarter net cannabis revenue to $2.35 million, alongside higher gross profit and an improved gross margin of 29%. The company also reduced its cash cost per gram so...
Business Operations and StrategyFinancial Disclosures
Greenway Leverages Efficiency Gains and International Expansion to Accelerate Next Growth Phase
Positive
Jan 5, 2026
In its 2025 year-in-review, Greenway highlighted a year of disciplined execution marked by improved cultivation efficiency, stronger yields and tighter cost controls, which management views as a durable step-change underpinning its profitability s...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.